Prof Kelly Cordoro (San Francisco, USA)
Dr. Kelly Cordoro is Professor of Dermatology and Pediatrics at the University of California, San Francisco. She received her MD at the Pennsylvania State University College of Medicine, completed Dermatology residency at the University of Virginia and a Pediatric Dermatology Fellowship at UCSF. She is the Division Chief of Pediatric Dermatology and the Pediatric Dermatology Fellowship Director at UCSF. Dr. Cordoro’s clinical focus is complex medical dermatology, particularly inflammatory diseases, in children, as well as laser surgery and procedures. Her primary research interest is pediatric psoriasis, but she has also studied pediatric melanoma, laser outcomes in children with disfiguring vascular anomalies, and the psychological impact of skin disease. Dr. Cordoro is a passionate educator, has won several teaching awards, and holds various leadership positions within dermatology nationally and internationally.
Prof Michele De Luca (Modena, Italy)
Michele De Luca, MD, is Director of the Centre for Regenerative Medicine “Stefano Ferrari” and the Interdepartmental Centre for Stem Cells and Regenerative Medicine at the University of Modena and Reggio Emilia and Scientific Director and co-founder of the university spin-off Holostem Terapie Avanzate.
De Luca was Scientific Director of Veneto Eye Bank Foundation in Venice (2000-2007) and Head of Laboratory of Tissue Engineering at Istituto Dermopatico dell’Immacolata in Rome (1996-2002), Deputy Head (1992-1995) and Senior Investigator (1986-1992) at Laboratory of Stem Cell Differentiation at National Institute for Cancer Research in Genova, Visiting scientist at the Department of Physiology and Biophysics of Harvard Medical School in Boston (1985) and Fogarty Fellow at the NIH (NIADDK) in Bethesda (1982-1985).
De Luca is author of over 120 peer reviewed international publications, has been invited speaker in approximately 200 international meetings worldwide. He is internationally recognized as a leading scientist in epithelial stem cell biology aimed at clinical application in regenerative medicine and played a pivotal role in epithelial stem cell-mediated cell and gene therapy.
Prof Inderjeet Dokal (London, United Kingdom)
Inderjeet Dokal graduated in Medicine from the University of Leicester in 1983. He moved to Hammersmith Hospital (London) in 1984 where he received his post graduate clinical and research training. He was appointed Consultant in Paediatric Haematology in 1995 and was conferred the title of Professor of Haematology at Imperial College London in 2003. In 2006 he was recruited to the Chair of Child Health at Barts and The London School of Medicine and Dentistry, Queen Mary University of London. He is also an Honorary Consultant in Haematology (Barts Health) and Centre Lead for Genomics and Child Health. He has had a longstanding clinical and research interest in bone marrow failure syndromes such as dyskeratosis congenita. In 2010 he was elected Fellow of The Academy of Medical sciences.
Dr Danya Glaser (London, United Kingdom)
Dr Danya Glaser, initially a developmental paediatrician, then trained as a child and adolescent psychiatrist. She has practised, taught, researched and written widely on various aspects of child maltreatment including sexual and emotional abuse, neglect, and fabricated or induced illness (FII); child maltreatment and the Law with extensive expert witness work; the effects of child maltreatment on the developing brain; and Attachment. She is Visiting Professor at UCL and was Honorary Consultant Child & Adolescent Psychiatrist at Great Ormond Street Hospital for Children London UK, working on the early recognition of FII. Dr Glaser is a past president of ISPCAN.
Prof Alan Irvine (Dublin, Ireland)
Alan is a Consultant Dermatologist in Children’s Health Ireland and St. James’s Hospital, Dublin, and Professor of Dermatology, Trinity College Dublin. He is a recognised and sought-after international expert in epithelial genetics, characterisation of the skin barrier, disease mechanisms in, and therapy of atopic dermatitis and allergy.
His international awards include the 2006 Times Higher Education Supplement Research Project of the Year and 2007 Paul Gerson Unna Prize (German Dermatology Society). He has delivered serval named/prize lectureships including the MB Sulzberger (AAD, 2018), Honig (CHOP/U Penn, 2018), RW Goltz (U Minnesota, 2016), Watson-Smith (RCP Edinburgh, 2015), Dolovich (AAAAI, 2013) Lectures. In 2015, Alan was made an inaugural director of the International Eczema Council, an international body of experts dedicated to the study and treatment of atopic dermatitis. In 2019 he was elected to the Royal Irish Academy.
Prof Amy Paller (Illinois, USA)
Amy Paller, MS, MD is the Walter J. Hamlin Chair and Professor of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center (SBDRC) at Northwestern University’s Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University. Dr. Paller completed residency training in both Pediatrics and Dermatology at Northwestern University and her postdoctoral research fellowship at the University of North Carolina. She served as Chief of Pediatric Dermatology at Northwestern’s Children’s Hospital until she became Chair of Dermatology in 2004. An author of more than 450 peer-reviewed publications, Dr. Paller is an NIH-funded investigator in both her laboratory-based and clinical research. She has directed the Pediatric Dermatology Clinical Trials Unit at Northwestern/ Lurie Children’s for the past 25 years and has been the lead investigator on several landmark trials in pediatric skin disease. Her laboratory is currently focused on: a) inflammatory skin disorders and abnormal innervation; and b) topically delivered gene-suppressing nanotherapy for skin disorders. She has served the NIH on both NIAMS Council and its Board of Scientific Counselors, and currently serves on the NIH Advisory Committee on Research on Women’s Health. Dr. Paller has been President of the Society for Investigative Dermatology, the Society for Pediatric Dermatology, the Women’s Dermatologic Society, the Pediatric Dermatology Research Alliance, the International Eczema Council, and currently the International Society for Pediatric Dermatology. She has also served on the Board of Directors of the American Academy of Dermatology, the Society for Investigative Dermatology, the Society for Pediatric Dermatology, the Women’s Dermatologic Society, the American Dermatological Association, the International Society for Pediatric Dermatology and the International Eczema Council. She has co-edited several leading textbooks of dermatology, most notably Fitzpatrick’s Dermatology in General Medicine, and co-authors Hurwitz’s Clinical Pediatric Dermatology. She has been an Associate Editor of the Journal of Investigative Dermatology and has served on the editorial boards of several other journals. She has received numerous honors, among them the Stephen Rothman Award from the Society for Investigative Dermatology, Mentor of the Year, Rose Hirschler, and the Wilma Bergfeld, MD Visionary & Leadership awards from the Women’s Dermatological Society, the Clarence S. Livingood, MD Memorial Award from the AAD, the Founder’s Award from the Chicago Dermatological Society, and the inaugural Paula Stern Outstanding Women in Science and Medicine Award from Northwestern University. An avid advocate for patients with skin disease, Dr. Paller serves on numerous boards for dermatology patient advocacy organizations.
Dr Virginia Sybert (Washington, USA)
Dr. Sybert is a pediatric dermatologist and medical geneticist with an interest in inherited skin conditions and Turner syndrome. She received her undergraduate degree in Philosophy at the University of Wisconsin, Madison, her medical degree from the State University of New York at Buffalo, trained in pediatrics at the University of California at San Francisco, and completed her fellowships in medical genetics and dermatology at the University of Washington in Seattle, where she has practiced both specialities for the last 39 years. She is the author of Genetic Skin Disorders, Oxford University Press, which is now in its third edition. She had the privilege of being a longtime Associate Editor of Pediatric Dermatology. She has an opinion about everything and knowledge about not nearly enough; the former she is happy to share and the latter she continues to try to augment.
Prof Pierre Vabres (Dijon, France)
Pierre Vabres, MD, is Professor and Chair of Dermatology, Department of Dermatology – University Hospital, Dijon, France (since 2005). He holds his expertise in Pediatric Dermatology and Genodermatology, particularly in the diagnosis and innovative treatment of rare genodermatoses and skin development anomalies. He manages a national reference center for rare genetic skin diseases (MAGEC), specialized in skin mosaic syndromes
His research activity at INSERM unit UMR1231 focuses primarily on innovative translational and personalized approaches in dermatology. He coordinates a nationwide research project on identification of new genes involved in skin mosaic syndromes through whole genome and next generation sequencing, and clinical delineation and deep phenotyping of rare genetic skin conditions. He has been a principal investigator for clinical trials of drug repurposing in rare mosaic cutaneous and overgrowth syndromes such as the PIK3CA-related overgrowth spectrum. He is also involved in a multidisciplinary research project on the psychosocial impact of cosmetic disability related to congenital skin anomalies.
He has authored over 150 articles in peer-reviewed journals and has given numerous conferences as an invited speaker at international meetings of dermatology societies. He is a board member of the ESPD (European Society for Pediatric Dermatology) and SFDP (Société Française de Dermatologie Pédiatrique), member of the SPD (Society for Pediatric Dermatology). He is a member of the Editorial Board of Dermatology (Basel).
Prof Gil Yosipovitch (Florida, USA)
Gil Yosipovitch, MD is a Tenured Professor of Dermatology at the Miller School of Medicine at University of Miami, and Director of the Miami Itch Center. Prior to joining the faculty of University of Miami, Dr. Yosipovitch chaired the Department of Dermatology at Temple University and directed the first translational, clinical and research center dedicated to the study of chronic itch in the US. He has been awarded dozens of grants from the government, industry and private foundations . He has published more than 400 articles in books and peer reviewed journals and has edited 5 books. He is the founder and past president of the International Forum for the Study of Itch and served on the editorial boards of 6 key specialty journals. He is currently the Director of the National Eczema Association Scientific Advisory Board. He received one of the highest awards in dermatology, the Marion B. Sulzberger lectureship award, at the 2016 AAD meeting. Dr. Yosipovitch was awarded several other prestigious awards for his research and work including the Heinz Maurer prize by the German Dermatology Society in 1998, The Clinical Investigator Award of Wake Forest University, the inaugural Jeff Bernhard award in the World Conference of Itch in 2013, the highest award of Worclaw University Medical School in 2017 and the Ig Nobel in 2019. Dr. Yosipovitch has given more than 500 invited lectures to dermatology groups and organizations around the world and has mentored more than 30 fellows, PhD students and post-Doc fellows.
The Edinburgh Convention Bureau has been appointed as the hotel booking service for the Meeting and competitive rates have been secured at a wide selection of hotels both close to the venue and in the City Centre.
To book accommodation for this event, please click (link coming soon)
+44 (0) 131 473 3874
Flights to Edinburgh arrive into Edinburgh Airport, which lies to the west of the city in Ingliston. Transport links from the airport are frequent, easy and fast.
For further information on travel from the airport to central Edinburgh click here